| Patient | Marilyn Monroe |
|---|---|
| Date of birth | 1926-06-01 |
| Identifiers | MRN HR-ML002-SYN-TD; SSN (made up) 000-02-4471 |
| Document date | 1956-10-26 |
| Author | Joanna Whitlock, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review: physical therapy, follow-up ultrasound, mood, and pregnancy plans. [S]
Ms. Monroe returns six weeks after the three-month visit, having had six sessions of pelvic floor physical therapy. She does her home program most days. Pain with intercourse is now mild and occasional, and her worst pelvic pain in the past week was 2 of 10. She continues the continuous pill with no periods and has used naproxen on two days this month. Her repeat transvaginal ultrasound this morning was reviewed by Dr. Okoye. She has had no thoughts of suicide or self-harm. She and her spouse want to begin trying for a pregnancy in about eight months, and she asks what the steps will be. [S]
| Element | Detail |
|---|---|
| Physical therapy | Six sessions; home program most days |
| Pain | Worst 2 of 10; mild, occasional pain with intercourse |
| Treatment | Continuous combined pill; naproxen on two days this month |
| Mood | PHQ-9 4, GAD-7 3 |
| Pregnancy plans | Would like to begin trying in about eight months |
| System | Result | Finding |
|---|---|---|
| Genitourinary | Negative | No bleeding; only mild, occasional pain with intercourse; no urinary symptoms |
| Gastrointestinal | Negative | No bowel pain |
| Musculoskeletal | Negative | No hip or back pain |
| Psychiatric | Negative | Mood good; no thoughts of suicide or self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet, one tablet by mouth twice daily with food, from two days before an expected bleed until the third day, and for pain flares; no more than 10 days a month | One tablet by mouth twice daily with food when needed for pelvic pain | Oral route | 1956-06-15 | active | S |
| Ethinyl estradiol 0.02 mg and norethindrone acetate 1 mg oral tablet, one tablet by mouth daily, taken continuously without a pill-free week | One tablet by mouth daily, continuously | Oral route | 1956-06-15 | active | S |
| Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days | One capsule by mouth twice daily with food for 5 days | Oral route | 1956-07-20 to 1956-07-24 | completed | S |
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1956-08-17 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1956-10-26 | Body height | 166 | cm | S |
| 1956-10-26 | Body weight | 56.6 | kg | S |
| 1956-10-26 | Body mass index (BMI) [Ratio] | 20.5 | kg/m2 | S |
| 1956-10-26 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1956-10-26 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1956-10-26 | Heart rate | 70 | /min | S |
| 1956-10-26 | Respiratory rate | 14 | /min | S |
| 1956-10-26 | Body temperature | 36.6 | Cel | S |
| 1956-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1956-10-26 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1956-10-26 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S | ||
| 1956-10-26 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S |
Vital signs recorded on 1956-10-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 112/70, pulse 70; weight 56.6 kg |
| Pelvic | Levator ani muscles relaxed, with only slight tenderness on the left; mild left adnexal fullness; no nodule |
| Psychiatric | Euthymic; engaged; organized |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Severe painful periods since her teens, worse over the past three years, with pelvic pain between periods, deep pain with intercourse, and painful bowel movements during periods; she misses work for two or three days each cycle. Tender, slightly fixed retroverted uterus with tenderness and fullness in the left adnexa and along the left uterosacral ligament. Suspected endometriosis; transvaginal ultrasound and gynecology consultation booked | resolved | confirmed | N94.6 | S — Synthetic presenting problem linked to her documented endometriosis; superseded by the diagnosis at the consultation. |
| Endometriosis: a 3.4 cm left ovarian endometrioma on transvaginal ultrasound, with a tender, thickened left uterosacral ligament and no deep nodule of the bowel or bladder seen; diagnosed from imaging and examination without surgery, as the ESHRE guideline allows. Synthetic modern episode linked to her documented endometriosis | active | confirmed | N80.102 | S — Synthetic modern diagnosis made at the gynecology consultation; depth is unspecified because no surgery was done. |
| Major depressive disorder, single episode, moderate: about two months of low mood, poor sleep on painful nights, low energy, guilt about missed work, and poor concentration (PHQ-9 12, item 9 scored 0; GAD-7 8); Mood Disorder Questionnaire negative; no thoughts of suicide or self-harm | active | confirmed | F32.1 | S — Synthetic modern diagnosis; the historical and retrospective mental-health accounts are not coded. |
| Acute uncomplicated cystitis: one day of burning, frequency and urgency with suprapubic discomfort, without fever, flank pain or blood in the urine; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; resolved | resolved | confirmed | N30.00 | S — Synthetic acute infection; not a historical claim. |
| Pelvic floor muscle dysfunction with myofascial pain: deep pain with intercourse that persisted after three months of hormonal suppression, with tender, tight levator ani muscles that reproduce the pain on examination | active | confirmed | M62.89 | S — Synthetic modern finding; a common companion of endometriosis pain. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pelvic pain score (0 to 10), pain with intercourse and bowel movements, and missed working days | Every visit | Completed today | Worst pain 2 of 10; mild, occasional pain with intercourse; no missed work |
| Self-management | Bleeding pattern on continuous suppression | Every visit | Completed today | No periods |
| Medication safety | Combined pill: adherence, side effects, and reasons to stop estrogen (migraine with aura, high blood pressure, clot symptoms, smoking) | Every visit, with blood pressure | Completed today | Taken daily; blood pressure 112/70; no migraine with aura or clot symptoms |
| Medication safety | Naproxen: days used each month, and stomach or kidney symptoms | Every visit | Completed today | Two days this month |
| Medication safety | No opioid, benzodiazepine, or sleep-medicine accumulation; prescription monitoring program | At the start, then every visit while pain is active | Completed today | No opioid, benzodiazepine or sleep medicine |
| Imaging | Transvaginal ultrasound: endometrioma size and deep disease | At diagnosis; repeat at about four months on medical treatment, then yearly or if symptoms change | Completed today | Left endometrioma 3.1 by 2.6 cm, slightly smaller; no deep disease; next yearly |
| Examination | Pelvic examination | At diagnosis, and when pain persists or changes | Completed today | Pelvic floor relaxed; slight left tenderness |
| Referral | Surgical evaluation (laparoscopic excision) | If pain does not respond to medical treatment, the cyst grows, or imaging is atypical | Not indicated | Pain controlled and the cyst slightly smaller |
| Referral | Pelvic floor physical therapy | Weekly for six to eight weeks | Completed today | Six sessions; two more, then the home program |
| Self-management | Pregnancy intention and fertility plan | Every visit | Completed today | Wants to begin trying in about eight months; preconception visit planned; reproductive endocrinology after six months of trying |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, every 2 to 4 weeks in continuation, then periodically | Completed today | PHQ-9 4: remission |
| Survey | Anxiety measure (GAD-7) | At diagnosis and with each depression measure | Completed today | GAD-7 3 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Cognitive behavioral therapy engagement | Monthly in continuation | Completed today | Moving to monthly sessions |
| Self-management | Sleep without sedatives | Every visit | Completed today | Seven to eight hours without a sleep aid |
Goal progress:
Guideline basis: Practice Bulletin No. 114: Management of Endometriosis (2010); ESHRE guideline: endometriosis (2022); Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218 (2020); CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022); U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024); Anxiety Disorders in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Two more physical therapy sessions. Behavioral health monthly. Preconception visit in about seven months; endometriosis review sooner if pain returns. [S]